FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes a new agent with expressed selective blocking activity with regards to muscarinic receptors of subtype M4 taking part in control over the formation of cAMP and in activation of peptides Gi/Go. Agent represents 1-phenyl-1-cyclopentyl-4-piperidino-2-butyne-1-ol (pentifin) of the formula (I) known early as an agent used in treatment of Parkinson's disease. EFFECT: valuable medicinal properties of agent, expanded assortment of agents of indicated designation. 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
USING 1-PHENYL-1-(1'-METHYLCYCLOPENTYL)-4-PIPERIDINO-2-BUTYNE-1-OL HYDROCHLORIDE AS AGENT POSSESSING M1 CHOLINE-BLOCKING ACTIVITY | 2004 |
|
RU2273478C2 |
1-PHENYL-1-CYCLOPENTYL-4-PIPERIDINO-2 BUTIN-1-OLA HYDROCHLORIDE POSSESSING ACTIVITY IN TREATING AND PREVENTING PARKINSONISM | 1998 |
|
RU2184542C2 |
(1-METHYLPIPERIDIN-4-YL)-2-PROPYL PENTANOATE HYDROCHLORIDE, HAVING CHOLINOLYTIC AND ANTICONVULSANT ACTIVITY | 2019 |
|
RU2714135C1 |
ANTICHOLINERGIC AGENT | 1987 |
|
RU2014074C1 |
PEPTIDE AZEMYOPSYN SELECTIVELY REACTING WITH NICOTINE MUSCARINIC RECEPTORS AND APPLICABLE AS MYORELAXANT IN MEDICINE AND COSMETOLOGY | 2011 |
|
RU2473559C1 |
METHOD FOR DETERMINATION OF ERYTHROCYTES M-CHOLINOREACTIVITY | 2016 |
|
RU2652273C2 |
M1 MUSCARINE RECEPTOR AGONISTS FOR ANALGETIC THERAPY | 2004 |
|
RU2358735C2 |
APPLICATION OF N-DISMETILKLOSAPINE FOR HUMAN NEUROPSYCHIATRIC DISEASES TREATMENT | 2004 |
|
RU2336879C2 |
TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS | 2007 |
|
RU2477634C2 |
N-ALKYL-TROPINES AND N-ALKYL-NORTROPINES HAVING h-LYTIC, ANTIPARKINSONIAN, ANTIEPILEPTIC, ANALGESIC AND ANTIDEPRESSANT ACTIVITY | 2014 |
|
RU2597616C2 |
Authors
Dates
2004-02-27—Published
2002-10-17—Filed